The 9th New Pharmaceutical Technology and Engineering Conference Program
MATSUSHITA IMP HALL, Osaka, Japan / Organized by: New Pharmaceutical Technology and Engineering
Wed. July 13, 2011

Thurs. July 14, 2011

Coordinators: Prof. Yoshiaki Kawashima, Aichi Univ. / Dr. Kazuhiro Sako, Astelas Pharma Inc. / Prof. Hisakazu Sunada, Meijo Univ. / Prof. Hirofumi Takeuchi, Gifu Pharmaceutical Univ.
Dr. Yuji Tokunaga, Sawai Pharmaceutical Co., Ltd. / Prof. Keiji Yamamoto, Chiba Univ. / Dr. Naoki Wakiyama, Daiichi Sankyo

10：00～10：10

9：50～10：40"Openning Remarks"

110：10～111：00Prof. Hiroaki Okada
Emeritus Professor
Tokyo University of Pharmacy and Life Sciences"Current Situation on Nanotechnololgy and its Application to Drug Discovery"

10：40～
2
11：30

11：00～
11：50

Dr. Gordon T Muirhead
Vice President, Head of New Product Introduction, Global Manufacture and Supply,
GlaxoSmithKline"Powder In – Tablets Out; Continuous Processing"32

Mr. Hiroyuki Sawai
President, Japan Generic Medicines Associate (JGA)"At Last, Japan Faces the Era of Generic Medicines?"

Mr. Makoto Fukuda
Director, Pharmaceutical Technology Research & Development Laboratories, CMC Center
Takeda Pharmaceutical Company Ltd.
"Development and Formulation Design of Oral Fixed-Dose Combination"

11：30～
12：20

Mr. Jerry Parker
Former Associate Director of Pharmaceutical Development, Abbott, USA"Multi-Purpose OSD Development Facilities: Design Solutions for Specific Challenges"

12：20～
13：10

Lunch Time

11:50～
12:50

Lunch Time

12：50～
3
13：40

Dr. Motoya Kohtani
Senior Analyst, Pharmaceutical & Healthcare Industry Research Group
Equity Research Dept. III, Financial & Economic Reserch Center, Nomura Securities Co., Ltd"Pharmaceutical Industry from Global Points of View"

4

13：10～
14：00

Dr. Johann Mueller
Managing Director, Corden Pharma GmBH (Previously AstraZeneca)"High Containment Tablet Facility – An Example"

13：40～
4
14：30

Dr. Masanori Kobayasi
Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc.
"Oral Disintegrant Tablet Formulation Composed of Functional Fine Particles - fromdesign to commercialization - "5

14：00～
14：50

Dr. Shigeyoshi Otani
Advisor, Research Development, Nipro Corporation (Previously Shionogi Co., Ltd.)"Scalability of High-Speed Agitating Granulation and Solubility of Tablets"

14：30～
15：00

Dr. Ali Afnan
President, Step Change Pharma, Inc. (Former Director of FDA)"The Drivers for Pharmaceuticals Excellence"

15：10～
6
16：00

15：50～
16：40

Dr. Takayuki Ohwaki
Director of Drug Development Technology Center, Customer Joy Department, Eisai Co., Ltd.
"Development of Design Space by Fluid-Bed Granulation Method"

7

16：40～
17：00

Break

15：00～
515：50

6

14：50～
15：10

Coffee Break

17：00～
19：00

Networking Reception Party

Coffee BreakProf. Dr. Uwe Buecheler
Senior Vice President Biopharmaceuticals Operations
Biopharmaceuticals Operations, Boehringer Ingelheim Pharma GmbH & Co. KG"Biopharmaceutical Manufacturing Trends: Long-Term Viable Manufacturing Solutions"

16：00～
16：50

Dr. Masahiko Kikuchi
Vice President, Vaccine Business Planning Department, Diichi Sankyo Company Ltd.
"Developing Vaccine Business to Solve Public Health Problems"

16：50～
17：00"Closing Remarks"